Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis

被引：60

作者：

Andrews, GP ^{[1
]}

Strachan, ST ^{[1
]}

Benner, GE ^{[1
]}

Sample, AK ^{[1
]}

Anderson, GW ^{[1
]}

Adamovicz, JJ ^{[1
]}

Welkos, SL ^{[1
]}

Pullen, JK ^{[1
]}

Friedlander, AM ^{[1
]}

机构：

[1] USA, Med Res Inst Infect Dis, Div Bacteriol, Ft Detrick, MD 21702 USA

来源：

INFECTION AND IMMUNITY | 1999年 / 67卷 / 03期

关键词：

D O I：

10.1128/IAI.67.3.1533-1537.1999

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

To evaluate the role of Yersinia outer proteins (Yops) in conferring protective immunity against plague, six yap loci from Yersinia pestis were individually amplified by PCR, cloned, and expressed in Escherichia coli. The recombinant proteins were purified and injected into mice. Most Yop-vaccinated animals succumbed to infection with either wild-type encapsulated Y. pestis or a virulent, nonencapsulated isogenic variant. Vaccination with YpkA significantly prolonged mean survival time but did not increase overall survival of mice infected with the nonencapsulated strain. The only significant protection against death was observed in YopD-vaccinated mice challenged with the nonencapsulated strain.

引用

页码：1533 / 1537

页数：5

共 38 条

[1] Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis
Anderson, GW
Leary, SEC
Williamson, ED
Titball, RW
Welkos, SL
Worsham, PL
Friedlander, AM
[J]. INFECTION AND IMMUNITY, 1996, 64 (11) : 4580 - 4585
[2] YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis
Andersson, K
Carballeira, N
Magnusson, KE
Persson, C
Stendahl, O
WolfWatz, H
Fallman, M
[J]. MOLECULAR MICROBIOLOGY, 1996, 20 (05) : 1057 - 1069
[3] 2 NOVEL VIRULENCE LOCI, MXIA AND MXIB, IN SHIGELLA-FLEXNERI 2A FACILITATE EXCRETION OF INVASION PLASMID ANTIGENS
ANDREWS, GP
HROMOCKYJ, AE
COKER, C
MAURELLI, AT
[J]. INFECTION AND IMMUNITY, 1991, 59 (06) : 1997 - 2005
[4] Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge
Andrews, GP
Heath, DG
Anderson, GW
Welkos, SL
Friedlander, AM
[J]. INFECTION AND IMMUNITY, 1996, 64 (06) : 2180 - 2187
[5] BENNER GE, IN PRESS INFECT IMMU
[6] Identification of p130(Cas) as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions
Black, DS
Bliska, JB
[J]. EMBO JOURNAL, 1997, 16 (10) : 2730 - 2744
[7] Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y-enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus
Boland, A
Sory, MP
Iriarte, M
Kerbourch, C
Wattiau, P
Cornelis, GR
[J]. EMBO JOURNAL, 1996, 15 (19) : 5191 - 5201
[8] THE PLASMID-ENCODED YOP2B PROTEIN OF YERSINIA-PSEUDOTUBERCULOSIS IS A VIRULENCE DETERMINANT REGULATED BY CALCIUM AND TEMPERATURE AT THE LEVEL OF TRANSCRIPTION
BOLIN, I
WOLFWATZ, H
[J]. MOLECULAR MICROBIOLOGY, 1988, 2 (02) : 237 - 245
[9] BOLIN I, 1985, INFECT IMMUN, V48, P234
[10] *COMM CAR US LAB A, 1985, NIH PUBL, V8623

← 1 2 3 4 →